NCT00553202 · OUTCOME
Cumulative Incidence of NK Cell Reconstitution
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Percentage of participants
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- At 5 years from HSCT date
What was measured
Cumulative incidence of successful reconstitution to donor level is calculated.
Analysis population: Patients without completion of planned therapy (n=68) or without NK cell status (n=38) are excluded from analyses of TExp
Groups in this outcome
Treatment (Chemotherapy and Allogeneic SCT)
All Patients
| Group | Source count |
|---|---|
| Treatment (Chemotherapy and Allogeneic SCT) | 52 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Treatment (Chemotherapy and Allogeneic SCT) | 48.1 | Not reported | 33.8 | 61.0 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 33.8
- upper Limit
- 61.0
- value
- 48.1
- denoms
- counts
- group Id
- OG000
- value
- 52
- units
- Participants
- description
- Cumulative incidence of successful reconstitution to donor level is calculated.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- All Patients
- id
- OG000
- title
- Treatment (Chemotherapy and Allogeneic SCT)
- param Type
- NUMBER
- population Description
- Patients without completion of planned therapy (n=68) or without NK cell status (n=38) are excluded from analyses of TExp
- reporting Status
- POSTED
- time Frame
- At 5 years from HSCT date
- title
- Cumulative Incidence of NK Cell Reconstitution
- type
- PRIMARY
- unit Of Measure
- Percentage of participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle